Literature DB >> 33154041

Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal Maturation.

André A Weber1, Elvira Mennillo1, Xiaojing Yang1, Lori W E van der Schoor1, Johan W Jonker1, Shujuan Chen1, Robert H Tukey2.   

Abstract

UDP-glucuronosyltransferase (UGT) 1A1 is the only transferase capable of conjugating serum bilirubin. However, temporal delay in the development of the UGT1A1 gene leads to an accumulation of serum bilirubin in newborn children. Neonatal humanized UGT1 (hUGT1) mice, which accumulate severe levels of total serum bilirubin (TSB), were treated by oral gavage with obeticholic acid (OCA), a potent FXR agonist. OCA treatment led to dramatic reduction in TSB levels. Analysis of UGT1A1 expression confirmed that OCA induced intestinal and not hepatic UGT1A1. Interestingly, Cyp2b10, a target gene of the nuclear receptor CAR, was also induced by OCA in intestinal tissue. In neonatal hUGT1/Car -/- mice, OCA was unable to induce CYP2B10 and UGT1A1, confirming that CAR and not FXR is involved in the induction of intestinal UGT1A1. However, OCA did induce FXR target genes, such as Shp, in both intestines and liver with induction of Fgf15 in intestinal tissue. Circulating FGF15 activates hepatic FXR and, together with hepatic Shp, blocks Cyp7a1 and Cyp7b1 gene expression, key enzymes in bile acid metabolism. Importantly, the administration of OCA in neonatal hUGT1 mice accelerates intestinal epithelial cell maturation, which directly impacts on induction of the UGT1A1 gene and the reduction in TSB levels. Accelerated intestinal maturation is directly controlled by CAR, since induction of enterocyte marker genes sucrase-isomaltase, alkaline phosphatase 3, and keratin 20 by OCA does not occur in hUGT1/Car -/- mice. Thus, new findings link an important role for CAR in intestinal UGT1A1 induction and its role in the intestinal maturation pathway. SIGNIFICANCE STATEMENT: Obeticholic acid (OCA) activates FXR target genes in both liver and intestinal tissues while inducing intestinal UGT1A1, which leads to the elimination of serum bilirubin in humanized UGT1 mice. However, the induction of intestinal UGT1A1 and the elimination of bilirubin by OCA is driven entirely by activation of intestinal CAR and not FXR. The elimination of serum bilirubin is based on a CAR-dependent mechanism that facilitates the acceleration of intestinal epithelium cell differentiation, an event that underlies the induction of intestinal UGT1A1.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33154041      PMCID: PMC7745083          DOI: 10.1124/dmd.120.000240

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  43 in total

1.  Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice.

Authors:  Young Suk Jo; Dongryeol Ryu; Adriano Maida; Xu Wang; Ronald M Evans; Kristina Schoonjans; Johan Auwerx
Journal:  Hepatology       Date:  2015-07-22       Impact factor: 17.425

Review 2.  Managing the jaundiced newborn: a persistent challenge.

Authors:  M Jeffrey Maisels
Journal:  CMAJ       Date:  2014-11-10       Impact factor: 8.262

3.  Reduced Myelination and Increased Glia Reactivity Resulting from Severe Neonatal Hyperbilirubinemia.

Authors:  Andreia Barateiro; Shujuan Chen; Mei-Fei Yueh; Adelaide Fernandes; Helena Sofia Domingues; João Relvas; Olivier Barbier; Nghia Nguyen; Robert H Tukey; Dora Brites
Journal:  Mol Pharmacol       Date:  2015-10-19       Impact factor: 4.436

4.  Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus.

Authors:  Ryoichi Fujiwara; Nghia Nguyen; Shujuan Chen; Robert H Tukey
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

Review 5.  The clinical syndrome of bilirubin-induced neurologic dysfunction.

Authors:  Vinod K Bhutani; Lois Johnson-Hamerman
Journal:  Semin Fetal Neonatal Med       Date:  2015-01-07       Impact factor: 3.926

6.  6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.

Authors:  Roberto Pellicciari; Stefano Fiorucci; Emidio Camaioni; Carlo Clerici; Gabriele Costantino; Patrick R Maloney; Antonio Morelli; Derek J Parks; Timothy M Willson
Journal:  J Med Chem       Date:  2002-08-15       Impact factor: 7.446

7.  FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid.

Authors:  Elliot S Friedman; Yun Li; Ting-Chin David Shen; Jack Jiang; Lillian Chau; Luciano Adorini; Farah Babakhani; Jeffrey Edwards; David Shapiro; Chunyu Zhao; Rotonya M Carr; Kyle Bittinger; Hongzhe Li; Gary D Wu
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

8.  Differential Role of Liver X Receptor (LXR) α and LXRβ in the Regulation of UDP-Glucuronosyltransferase 1A1 in Humanized UGT1 Mice.

Authors:  Eva Hansmann; Elvira Mennillo; Emiko Yoda; Mélanie Verreault; Olivier Barbier; Shujuan Chen; Robert H Tukey
Journal:  Drug Metab Dispos       Date:  2020-01-24       Impact factor: 3.922

9.  Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis.

Authors:  Albert Parés; Mitchell Shiffman; Victor Vargas; Pietro Invernizzi; Elizabeth S Malecha; Alexander Liberman; Leigh MacConell; Gideon Hirschfield
Journal:  Liver Int       Date:  2020-03-24       Impact factor: 5.828

10.  NCoR1 Protects Mice From Dextran Sodium Sulfate-Induced Colitis by Guarding Colonic Crypt Cells From Luminal Insult.

Authors:  Elvira Mennillo; Xiaojing Yang; Miles Paszek; Johan Auwerx; Christopher Benner; Shujuan Chen
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.